Title:Senior Consultant
Degree/diploma:M.M.
Doctoral/master's supervisor:Master's Supervisor
Areas of focus:
(1) Radionuclide-targeted therapy for thyroid cancer: postoperative iodine-131 (I-131) treatment for differentiated thyroid cancer, with a highly accurate evaluation system for treatment planning and efficacy assessment and scientific diagnostic and therapeutic methods for I-131-resistant thyroid cancer
(2) Radionuclide therapy for hyperthyroidism
(3) Radionuclide treatment for metastatic bone tumors and other diseases: Radionuclide therapies, such as Strontium-89 (Sr-89) and Radium-223 (Ra-223)
(4) Integrated radionuclide diagnostics and therapy: Including targeted radionuclide therapies for prostate cancer.
(5) Radionuclide keloid therapy: Safe, reliable, and highly effective treatment for keloids.
(6) Clinical nuclear medicine imaging diagnostics with advanced PET/CT and SPECT/CT imaging equipment for diagnosing and screening for malignant tumors, cardiovascular diseases, pulmonary embolisms, thyroid diseases, kidney diseases, bone disorders, and parathyroid diseases
Biographical sketch
With 40 years of experience in clinical imaging and nuclear medicine therapy, Dr. LOU Cen has served as the Director and Academic Leader of the Department of Nuclear Medicine at SRRSH for 26 years. She has made outstanding contributions to medical care, scientific research, and education. Dr. Lou is the director of the National Nuclear Medicine Professional Residency Training Base and the National Clinical Pharmacology Nuclear Medicine Experimental Base. She has established and led the development of the SRRSH Nuclear Medicine Department, pioneering the first standardized large-scale radionuclide therapy ward in the country. The department has consistently ranked 5th in the reputation rankings for Nuclear Medicine specialties in East China, as per the Fudan University Hospital Rankings. She has contributed to over five national standardized nuclear medicine textbooks and published more than 50 professional papers in core journals. Her primary research areas include radionuclide imaging diagnostics and radionuclide-targeted therapy.
Professional memberships
Standing Committee Member and Deputy Chair of the Quality Control Working Committee, Chinese Society of Nuclear Medicine, Chinese Medical Association
President, Nuclear Medicine Physician Branch, Zhejiang Provincial Medical Doctor Association
Vice Chair, Yangtze River Delta Nuclear Medicine and Molecular Imaging Specialty Alliance
Standing Director, Chinese Society of Medical Imaging Technology